Craig R. Skenes
Corporate Officer/Principal bei AERIE PHARMACEUTICALS, INC.
Aktive Positionen von Craig R. Skenes
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| AERIE PHARMACEUTICALS, INC. | Corporate Officer/Principal | 16.06.2014 | - |
Karriereverlauf von Craig R. Skenes
Ausbildung von Craig R. Skenes
| The California State University | Masters Business Admin |
Statistik
International
| Vereinigte Staaten | 3 |
Operativ
| Corporate Officer/Principal | 1 |
| Masters Business Admin | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 2 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Aerie Pharmaceuticals, Inc.
 Aerie Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. Its products include Rhopressa, Roclatan, AR-13503, and AR-1105. The company was founded by David L. Epstein, Casey C. Kopczynski, Thomas J. van Haarlem, and Eric J. Toone on January 1, 2005 and is headquartered in Durham, NCForth Worth, TX. | Health Technology |
- Börse
- Insiders
- Craig R. Skenes
- Erfahrung
